Karibe A, Watanabe J, Horiguchi S, Takeuchi M, Suzuki S, Funakoshi M, Katoh H, Keitoku M, Satoh S, Shirato K
First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Am J Physiol. 1997 Mar;272(3 Pt 2):H1165-72. doi: 10.1152/ajpheart.1997.272.3.H1165.
Cytosolic Ca2+ and protein kinase C (PKC) may regulate the myogenic contraction of arterial myocytes. The role of these second messengers is examined in skeletal muscle small arteries, which have strong myogenic activity, and mesenteric small arteries, which have weak myogenic activity. The vessels were isolated and cannulated. The inner diameter was measured with a video-digitizing system. Cytosolic Ca2+ concentration was assessed by fura 2. Skeletal muscle small arteries dilated from 122 +/- 6 to 153 +/- 6 microm immediately after the transmural pressure change from 40 to 100 mmHg and constricted to 121 +/- 5 microm (myogenic contraction) with an increase in the 340/380 fluorescence ratio (by approximately 33%) in control vessels. Nifedipine abolished myogenic contraction and the increase in the fluorescence ratio. PKC inhibitors (H7 and staurosporine) abolished myogenic contraction but did not depress the increase in the fluorescence ratio. In mesenteric small arteries, myogenic contraction was insignificant in control vessels. A relatively low dose of PKC activator (4.4 +/- 1.4 nmol/l) elicited myogenic contraction, but a higher dose (21 +/- 6 nmol/l) depressed it. Thus the cytosolic Ca2+ increase and PKC activity may cooperatively act on the myogenic contraction of skeletal muscle small arteries. The activity of PKC should play an important role in myogenic contraction of rat small arteries.
胞质Ca2+和蛋白激酶C(PKC)可能调节动脉肌细胞的肌源性收缩。在具有强烈肌源性活动的骨骼肌小动脉和具有较弱肌源性活动的肠系膜小动脉中研究了这些第二信使的作用。分离并插管血管。用视频数字化系统测量内径。用fura 2评估胞质Ca2+浓度。在跨壁压力从40 mmHg变为100 mmHg后,骨骼肌小动脉立即从122±6微米扩张至153±6微米,并在对照血管中340/380荧光比值增加(约33%)时收缩至121±5微米(肌源性收缩)。硝苯地平消除了肌源性收缩和荧光比值的增加。PKC抑制剂(H7和星形孢菌素)消除了肌源性收缩,但未抑制荧光比值的增加。在肠系膜小动脉中,对照血管中的肌源性收缩不明显。相对低剂量的PKC激活剂(4.4±1.4 nmol/l)引起肌源性收缩,但较高剂量(21±6 nmol/l)则抑制它。因此,胞质Ca2+增加和PKC活性可能协同作用于骨骼肌小动脉的肌源性收缩。PKC的活性在大鼠小动脉的肌源性收缩中应起重要作用。